Toolkit/Booster-PKA
Booster-PKA
Taxonomy: Mechanism Branch / Architecture. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
Booster-PKA is a genetically encoded protein kinase A activity biosensor built on the red-shifted Booster Förster resonance energy transfer (FRET) backbone. It reports PKA signaling with performance comparable to AKAR3EV and can be used simultaneously with a CFP/YFP-based ERK FRET biosensor.
Usefulness & Problems
Why this is useful
Booster-PKA is useful for multiplexed live-cell signaling measurements in settings where standard CFP/YFP FRET biosensors would create spectral conflicts. The cited work specifically supports compatibility with CFP/YFP-based ERK FRET biosensors and with blue light-responsive optogenetic schemes described for the Booster platform.
Source:
Booster-PKA is a PKA activity biosensor built on the Booster red-shifted FRET backbone. It reports PKA signaling while remaining compatible with CFP/YFP biosensors and blue light optogenetic stimulation schemes described in the abstract.
Source:
monitoring PKA activity
Source:
simultaneous monitoring with CFP/YFP-based ERK FRET biosensors
Source:
monitoring PKA activation driven by a blue light-responsive optogenetic tool
Source:
imaging PKA activity in living tissues of transgenic mice
Problem solved
This tool addresses the problem of monitoring PKA activity while preserving the ability to image another kinase reporter based on CFP/YFP FRET in the same experiment. The supplied evidence supports its use for simultaneous monitoring of two protein kinase activities without relying solely on the standard CFP/YFP spectral channel set.
Source:
Booster-PKA provides a way to monitor PKA activity without the spectral conflicts of standard CFP/YFP FRET biosensors. This supports multiplexed kinase imaging and combination with blue light-responsive optogenetic control.
Source:
provides a red-shifted PKA FRET biosensor compatible with multiplexed imaging and blue light optogenetics
Problem links
provides a red-shifted PKA FRET biosensor compatible with multiplexed imaging and blue light optogenetics
LiteratureBooster-PKA provides a way to monitor PKA activity without the spectral conflicts of standard CFP/YFP FRET biosensors. This supports multiplexed kinase imaging and combination with blue light-responsive optogenetic control.
Source:
Booster-PKA provides a way to monitor PKA activity without the spectral conflicts of standard CFP/YFP FRET biosensors. This supports multiplexed kinase imaging and combination with blue light-responsive optogenetic control.
provides a red-shifted PKA FRET biosensor compatible with multiplexed imaging and blue-light optogenetic stimulation
LiteratureIt enables PKA activity imaging in settings where standard CFP/YFP biosensors would interfere with multiplexed FRET measurements or blue-light optogenetic tools.
Source:
It enables PKA activity imaging in settings where standard CFP/YFP biosensors would interfere with multiplexed FRET measurements or blue-light optogenetic tools.
Published Workflows
Objective: Develop a red-shifted genetically encoded FRET biosensor backbone that avoids the multiplexing and blue-light compatibility limitations of CFP/YFP-based biosensors, then demonstrate its utility in vitro and in vivo.
Why it works: The workflow pairs a favorable red-shifted donor/acceptor set selected by Förster distance calculations with biosensor architecture optimization, then tests whether the resulting design retains biosensor performance while reducing spectral conflicts with other FRET sensors and blue-light optogenetic tools.
Stages
- 1.Donor-acceptor pair selection by Förster distance calculation(in_silico_filter)
This stage identifies a donor/acceptor pair suitable for building a red-shifted FRET biosensor.
Selection: Favorable donor and acceptor pair chosen by calculating the Förster distance.
- 2.Biosensor backbone optimization(library_design)
This stage converts the selected fluorescent protein pair into a working biosensor backbone.
Selection: Optimization of fluorescent protein order and modulatory domains.
- 3.Benchmarking with a PKA biosensor implementation(functional_characterization)
This stage checks whether the red-shifted backbone retains useful biosensor performance after engineering.
Selection: Comparison of Booster-PKA performance to AKAR3EV.
- 4.Proof-of-concept compatibility demonstrations(confirmatory_validation)
This stage confirms that the engineered spectral shift solves the intended compatibility problems in live-cell use cases.
Selection: Demonstration of simultaneous kinase monitoring and compatibility with a blue light-responsive optogenetic tool.
- 5.In vivo tissue imaging in transgenic mice(in_vivo_validation)
This stage validates that the biosensor can function in living tissues in an animal context, extending beyond in vitro demonstrations.
Selection: Presentation of PKA activity in living tissues of transgenic mice expressing Booster-PKA.
Steps
- 1.Calculate Förster distance to choose donor and acceptor fluorescent proteins
Identify a favorable red-shifted donor/acceptor pair for the biosensor.
Pair selection is performed before biosensor backbone optimization because the fluorescent proteins define the core FRET pair used in the design.
- 2.Optimize fluorescent protein order and modulatory domains to build the Booster backboneengineered biosensor backbone
Convert the selected fluorescent protein pair into a functional red-shifted FRET biosensor backbone.
Architecture optimization follows pair selection because the chosen donor and acceptor must be arranged with modulatory domains to create a working biosensor.
- 3.Implement the Booster backbone as a PKA biosensor and compare it with AKAR3EVbiosensor under test and benchmark comparator
Determine whether the engineered red-shifted backbone retains practical biosensor performance.
Benchmarking occurs after backbone construction to verify that the redesigned sensor remains functionally comparable to an established PKA biosensor before broader application claims.
- 4.Test simultaneous monitoring with a CFP/YFP-based ERK FRET biosensorbiosensor under application test
Demonstrate multiplexed kinase activity imaging with a standard CFP/YFP-based FRET biosensor.
This proof-of-concept follows benchmarking because the authors next test whether the red-shifted design solves the intended multiplexing limitation.
- 5.Test monitoring of PKA activation driven by Beggiatoa photoactivated adenylyl cyclasebiosensor-actuator compatibility pair
Demonstrate compatibility of the red-shifted biosensor with a blue light-responsive optogenetic tool.
After showing multiplexed biosensor compatibility, the authors next test the second intended use case: compatibility with blue light-responsive optogenetic control.
- 6.Image PKA activity in living tissues of transgenic mice expressing Booster-PKAbiosensor under in vivo validation
Extend validation from in vitro proof-of-concept experiments to living tissue imaging in an animal model.
In vivo tissue imaging is presented last as a higher-context validation of versatility after in vitro compatibility demonstrations.
Objective: Develop a red-shifted genetically encoded FRET biosensor backbone that avoids the multiplexing and blue-light incompatibility limitations of CFP/YFP-based FRET biosensors, and demonstrate its utility with a PKA biosensor in vitro and in vivo.
Why it works: The workflow first addresses spectral design by selecting a favorable donor-acceptor pair and optimizing biosensor architecture, then tests whether the resulting backbone retains sensing performance while enabling multiplexing and blue-light optogenetic compatibility.
Stages
- 1.Fluorophore pair selection(in_silico_filter)
This stage identifies a donor-acceptor pair suitable for building red-shifted FRET biosensors.
Selection: Calculated Förster distance used to choose a favorable donor and acceptor pair.
- 2.Backbone optimization(library_design)
This stage converts the selected fluorophore pair into a working biosensor backbone.
Selection: Optimization of the order of fluorescent proteins and modulatory domains.
- 3.Comparator performance testing(confirmatory_validation)
This stage checks whether the red-shifted backbone preserves performance relative to an established CFP/YFP PKA biosensor.
Selection: Comparison of Booster-PKA performance to AKAR3EV.
- 4.Multiplexing proof of concept(functional_characterization)
This stage tests whether the red-shifted design enables simultaneous use with standard CFP/YFP biosensors.
Selection: Ability to monitor two protein kinase activities simultaneously with Booster-PKA and a CFP/YFP ERK FRET biosensor.
- 5.Optogenetic compatibility testing(functional_characterization)
This stage tests whether the red-shifted biosensor can operate with a blue-light optogenetic actuator that would conflict with CFP/YFP biosensors.
Selection: Ability to monitor PKA activation driven by Beggiatoa photoactivated adenylyl cyclase.
- 6.In vivo tissue demonstration(in_vivo_validation)
This stage extends validation from in vitro demonstrations to living tissues in transgenic mice.
Selection: Presentation of PKA activity in living tissues of transgenic mice expressing Booster-PKA.
Steps
- 1.Calculate Förster distance to choose donor and acceptor pair
Identify a favorable fluorescent protein pair for a red-shifted FRET biosensor.
Pair selection is done before backbone optimization because the chosen donor and acceptor define the spectral basis of the biosensor.
- 2.Optimize fluorescent protein and modulatory domain order to build Boosterengineered biosensor backbone
Convert the selected fluorophore pair into a functional red-shifted FRET biosensor backbone.
Architecture optimization follows fluorophore selection because domain order must be tuned around the chosen donor-acceptor pair.
- 3.Benchmark Booster-PKA against AKAR3EVbiosensor and comparator
Test whether the red-shifted PKA biosensor preserves performance relative to an established CFP/YFP biosensor.
Comparator benchmarking is performed after backbone construction to confirm that solving spectral compatibility did not compromise sensing performance.
- 4.Test simultaneous kinase monitoring with Booster-PKA and a CFP/YFP ERK biosensorbiosensor under application test
Demonstrate multiplexed monitoring of two kinase activities in the same setting.
This application test follows comparator benchmarking because multiplexing is a key intended advantage once baseline performance is established.
- 5.Monitor PKA activation driven by Beggiatoa photoactivated adenylyl cyclasebiosensor and optogenetic actuator
Demonstrate compatibility of the red-shifted biosensor with a blue-light optogenetic cAMP generator.
This test follows multiplexing proof of concept because blue-light compatibility is another central design goal enabled by spectral red-shifting.
- 6.Present PKA activity in living tissues of transgenic mice expressing Booster-PKAbiosensor under in vivo validation
Demonstrate that the biosensor can report PKA activity in living mouse tissues.
In vivo demonstration is placed after in vitro proof-of-concept tests as a higher-fidelity validation of practical imaging utility.
Taxonomy & Function
Primary hierarchy
Mechanism Branch
Architecture: A reusable architecture pattern for arranging parts into an engineered system.
Techniques
No technique tags yet.
Target processes
signalingInput: Light
Implementation Constraints
Booster-PKA is a construct based on the Booster red-shifted FRET backbone and requires expression in cells or tissues for live imaging. The described applications involve pairing it with a CFP/YFP-based ERK FRET biosensor, and the broader Booster platform was described as compatible with blue light-responsive optogenetic tools.
The supplied evidence does not show that Booster-PKA outperforms AKAR3EV; it only supports comparable performance. The evidence is limited to PKA sensing and multiplexing with a CFP/YFP-based ERK biosensor, with no additional validation details provided here on dynamic range, kinetics, cell types, or in vivo use.
Validation
Supporting Sources
Ranked Claims
Booster-PKA can be used simultaneously with a CFP/YFP-based ERK FRET biosensor to monitor activities of two protein kinases.
we first showed simultaneous monitoring of activities of two protein kinases with Booster-PKA and ERK FRET biosensors based on CFP and YFP
Booster-PKA can be used simultaneously with a CFP/YFP-based ERK FRET biosensor to monitor activities of two protein kinases.
we first showed simultaneous monitoring of activities of two protein kinases with Booster-PKA and ERK FRET biosensors based on CFP and YFP
Booster-PKA can be used simultaneously with a CFP/YFP-based ERK FRET biosensor to monitor activities of two protein kinases.
we first showed simultaneous monitoring of activities of two protein kinases with Booster-PKA and ERK FRET biosensors based on CFP and YFP
Booster-PKA can be used simultaneously with a CFP/YFP-based ERK FRET biosensor to monitor activities of two protein kinases.
we first showed simultaneous monitoring of activities of two protein kinases with Booster-PKA and ERK FRET biosensors based on CFP and YFP
Booster-PKA can be used simultaneously with a CFP/YFP-based ERK FRET biosensor to monitor activities of two protein kinases.
we first showed simultaneous monitoring of activities of two protein kinases with Booster-PKA and ERK FRET biosensors based on CFP and YFP
Booster-PKA can be used simultaneously with a CFP/YFP-based ERK FRET biosensor to monitor activities of two protein kinases.
we first showed simultaneous monitoring of activities of two protein kinases with Booster-PKA and ERK FRET biosensors based on CFP and YFP
Booster-PKA can be used simultaneously with a CFP/YFP-based ERK FRET biosensor to monitor activities of two protein kinases.
we first showed simultaneous monitoring of activities of two protein kinases with Booster-PKA and ERK FRET biosensors based on CFP and YFP
Booster-PKA can be used simultaneously with a CFP/YFP-based ERK FRET biosensor to monitor activities of two protein kinases.
we first showed simultaneous monitoring of activities of two protein kinases with Booster-PKA and ERK FRET biosensors based on CFP and YFP
Booster-PKA enabled simultaneous monitoring of two protein kinase activities together with a CFP/YFP-based ERK FRET biosensor.
For the proof of concept, we first showed simultaneous monitoring of activities of two protein kinases with Booster-PKA and ERK FRET biosensors based on CFP and YFP.
Booster-PKA performance was comparable to AKAR3EV.
The performance of the protein kinase A (PKA) biosensor based on the Booster backbone (Booster-PKA) was comparable to that of AKAR3EV
Booster-PKA performance was comparable to AKAR3EV.
The performance of the protein kinase A (PKA) biosensor based on the Booster backbone (Booster-PKA) was comparable to that of AKAR3EV
Booster-PKA performance was comparable to AKAR3EV.
The performance of the protein kinase A (PKA) biosensor based on the Booster backbone (Booster-PKA) was comparable to that of AKAR3EV
Booster-PKA performance was comparable to AKAR3EV.
The performance of the protein kinase A (PKA) biosensor based on the Booster backbone (Booster-PKA) was comparable to that of AKAR3EV
Booster-PKA performance was comparable to AKAR3EV.
The performance of the protein kinase A (PKA) biosensor based on the Booster backbone (Booster-PKA) was comparable to that of AKAR3EV
Booster-PKA performance was comparable to AKAR3EV.
The performance of the protein kinase A (PKA) biosensor based on the Booster backbone (Booster-PKA) was comparable to that of AKAR3EV
Booster-PKA performance was comparable to AKAR3EV.
The performance of the protein kinase A (PKA) biosensor based on the Booster backbone (Booster-PKA) was comparable to that of AKAR3EV
Booster-PKA performance was comparable to AKAR3EV.
The performance of the protein kinase A (PKA) biosensor based on the Booster backbone (Booster-PKA) was comparable to that of AKAR3EV
Booster-PKA performance was comparable to AKAR3EV.
The performance of the protein kinase A (PKA) biosensor based on the Booster backbone (Booster-PKA) was comparable to that of AKAR3EV
Booster-PKA performance was comparable to AKAR3EV.
The performance of the protein kinase A (PKA) biosensor based on the Booster backbone (Booster-PKA) was comparable to that of AKAR3EV
Booster-PKA performance was comparable to AKAR3EV.
The performance of the protein kinase A (PKA) biosensor based on the Booster backbone (Booster-PKA) was comparable to that of AKAR3EV
Booster-PKA performance was comparable to AKAR3EV.
The performance of the protein kinase A (PKA) biosensor based on the Booster backbone (Booster-PKA) was comparable to that of AKAR3EV
Booster-PKA performance was comparable to AKAR3EV.
The performance of the protein kinase A (PKA) biosensor based on the Booster backbone (Booster-PKA) was comparable to that of AKAR3EV
Booster-PKA performance was comparable to AKAR3EV.
The performance of the protein kinase A (PKA) biosensor based on the Booster backbone (Booster-PKA) was comparable to that of AKAR3EV
Booster-PKA performance was comparable to AKAR3EV.
The performance of the protein kinase A (PKA) biosensor based on the Booster backbone (Booster-PKA) was comparable to that of AKAR3EV
Booster-PKA performance was comparable to that of AKAR3EV.
The performance of the protein kinase A (PKA) biosensor based on the Booster backbone (Booster-PKA) was comparable to that of AKAR3EV, a previously developed FRET biosensor comprising CFP and YFP.
Booster-PKA can be used simultaneously with a CFP/YFP-based ERK FRET biosensor to monitor two protein kinase activities.
we first showed simultaneous monitoring of activities of two protein kinases with Booster-PKA and ERK FRET biosensors based on CFP and YFP
Booster-PKA can be used simultaneously with a CFP/YFP-based ERK FRET biosensor to monitor two protein kinase activities.
we first showed simultaneous monitoring of activities of two protein kinases with Booster-PKA and ERK FRET biosensors based on CFP and YFP
Booster-PKA can be used simultaneously with a CFP/YFP-based ERK FRET biosensor to monitor two protein kinase activities.
we first showed simultaneous monitoring of activities of two protein kinases with Booster-PKA and ERK FRET biosensors based on CFP and YFP
Booster-PKA can be used simultaneously with a CFP/YFP-based ERK FRET biosensor to monitor two protein kinase activities.
we first showed simultaneous monitoring of activities of two protein kinases with Booster-PKA and ERK FRET biosensors based on CFP and YFP
Booster-PKA can be used simultaneously with a CFP/YFP-based ERK FRET biosensor to monitor two protein kinase activities.
we first showed simultaneous monitoring of activities of two protein kinases with Booster-PKA and ERK FRET biosensors based on CFP and YFP
Booster-PKA can be used simultaneously with a CFP/YFP-based ERK FRET biosensor to monitor two protein kinase activities.
we first showed simultaneous monitoring of activities of two protein kinases with Booster-PKA and ERK FRET biosensors based on CFP and YFP
Booster-PKA can be used simultaneously with a CFP/YFP-based ERK FRET biosensor to monitor two protein kinase activities.
we first showed simultaneous monitoring of activities of two protein kinases with Booster-PKA and ERK FRET biosensors based on CFP and YFP
Booster-PKA enabled monitoring of PKA activation driven by Beggiatoa photoactivated adenylyl cyclase.
we showed monitoring of PKA activation by Beggiatoa photoactivated adenylyl cyclase, an optogenetic generator of cyclic AMP
Booster-PKA enabled monitoring of PKA activation driven by Beggiatoa photoactivated adenylyl cyclase.
we showed monitoring of PKA activation by Beggiatoa photoactivated adenylyl cyclase, an optogenetic generator of cyclic AMP
Booster-PKA enabled monitoring of PKA activation driven by Beggiatoa photoactivated adenylyl cyclase.
we showed monitoring of PKA activation by Beggiatoa photoactivated adenylyl cyclase, an optogenetic generator of cyclic AMP
Booster-PKA enabled monitoring of PKA activation driven by Beggiatoa photoactivated adenylyl cyclase.
we showed monitoring of PKA activation by Beggiatoa photoactivated adenylyl cyclase, an optogenetic generator of cyclic AMP
Booster-PKA enabled monitoring of PKA activation driven by Beggiatoa photoactivated adenylyl cyclase.
we showed monitoring of PKA activation by Beggiatoa photoactivated adenylyl cyclase, an optogenetic generator of cyclic AMP
Booster-PKA enabled monitoring of PKA activation driven by Beggiatoa photoactivated adenylyl cyclase.
we showed monitoring of PKA activation by Beggiatoa photoactivated adenylyl cyclase, an optogenetic generator of cyclic AMP
Booster-PKA enabled monitoring of PKA activation driven by Beggiatoa photoactivated adenylyl cyclase.
we showed monitoring of PKA activation by Beggiatoa photoactivated adenylyl cyclase, an optogenetic generator of cyclic AMP
Booster-PKA is compatible with blue-light optogenetic activation of cAMP signaling using Beggiatoa photoactivated adenylyl cyclase.
Second, we showed monitoring of PKA activation by Beggiatoa photoactivated adenylyl cyclase, an optogenetic generator of cyclic AMP.
Booster-PKA is compatible with blue-light optogenetic activation of cAMP signaling using Beggiatoa photoactivated adenylyl cyclase.
Second, we showed monitoring of PKA activation by Beggiatoa photoactivated adenylyl cyclase, an optogenetic generator of cyclic AMP.
Booster-PKA is compatible with blue-light optogenetic activation of cAMP signaling using Beggiatoa photoactivated adenylyl cyclase.
Second, we showed monitoring of PKA activation by Beggiatoa photoactivated adenylyl cyclase, an optogenetic generator of cyclic AMP.
Booster-PKA is compatible with blue-light optogenetic activation of cAMP signaling using Beggiatoa photoactivated adenylyl cyclase.
Second, we showed monitoring of PKA activation by Beggiatoa photoactivated adenylyl cyclase, an optogenetic generator of cyclic AMP.
Booster-PKA is compatible with blue-light optogenetic activation of cAMP signaling using Beggiatoa photoactivated adenylyl cyclase.
Second, we showed monitoring of PKA activation by Beggiatoa photoactivated adenylyl cyclase, an optogenetic generator of cyclic AMP.
Booster-PKA is compatible with blue-light optogenetic activation of cAMP signaling using Beggiatoa photoactivated adenylyl cyclase.
Second, we showed monitoring of PKA activation by Beggiatoa photoactivated adenylyl cyclase, an optogenetic generator of cyclic AMP.
Booster-PKA is compatible with blue-light optogenetic activation of cAMP signaling using Beggiatoa photoactivated adenylyl cyclase.
Second, we showed monitoring of PKA activation by Beggiatoa photoactivated adenylyl cyclase, an optogenetic generator of cyclic AMP.
Booster-PKA is compatible with blue-light optogenetic activation of cAMP signaling using Beggiatoa photoactivated adenylyl cyclase.
Second, we showed monitoring of PKA activation by Beggiatoa photoactivated adenylyl cyclase, an optogenetic generator of cyclic AMP.
Booster-PKA was used to monitor PKA activation driven by Beggiatoa photoactivated adenylyl cyclase.
Second, we showed monitoring of PKA activation by Beggiatoa photoactivated adenylyl cyclase, an optogenetic generator of cyclic AMP.
The Booster design selected mKOκ and mKate2 as the donor and acceptor pair based on calculated Förster distance.
We chose mKOκ and mKate2 as the favorable donor and acceptor pair by calculating the Förster distance.
The Booster design selected mKOκ and mKate2 as the donor and acceptor pair based on calculated Förster distance.
We chose mKOκ and mKate2 as the favorable donor and acceptor pair by calculating the Förster distance.
The Booster design selected mKOκ and mKate2 as the donor and acceptor pair based on calculated Förster distance.
We chose mKOκ and mKate2 as the favorable donor and acceptor pair by calculating the Förster distance.
The Booster design selected mKOκ and mKate2 as the donor and acceptor pair based on calculated Förster distance.
We chose mKOκ and mKate2 as the favorable donor and acceptor pair by calculating the Förster distance.
The Booster design selected mKOκ and mKate2 as the donor and acceptor pair based on calculated Förster distance.
We chose mKOκ and mKate2 as the favorable donor and acceptor pair by calculating the Förster distance.
The Booster design selected mKOκ and mKate2 as the donor and acceptor pair based on calculated Förster distance.
We chose mKOκ and mKate2 as the favorable donor and acceptor pair by calculating the Förster distance.
The Booster design selected mKOκ and mKate2 as the donor and acceptor pair based on calculated Förster distance.
We chose mKOκ and mKate2 as the favorable donor and acceptor pair by calculating the Förster distance.
The Booster design selected mKOκ and mKate2 as the donor and acceptor pair based on calculated Förster distance.
We chose mKOκ and mKate2 as the favorable donor and acceptor pair by calculating the Förster distance.
Booster is a red-shifted genetically encoded FRET biosensor backbone developed to overcome limitations of CFP/YFP-based FRET biosensors for multiplexing and blue-light optogenetic compatibility.
To overcome these problems, here, we have developed FRET biosensors with red-shifted excitation and emission wavelengths... we developed a FRET biosensor backbone named "Booster".
Booster is a red-shifted genetically encoded FRET biosensor backbone developed to overcome limitations of CFP/YFP-based FRET biosensors for multiplexing and blue-light optogenetic compatibility.
To overcome these problems, here, we have developed FRET biosensors with red-shifted excitation and emission wavelengths... we developed a FRET biosensor backbone named "Booster".
Booster is a red-shifted genetically encoded FRET biosensor backbone developed to overcome limitations of CFP/YFP-based FRET biosensors for multiplexing and blue-light optogenetic compatibility.
To overcome these problems, here, we have developed FRET biosensors with red-shifted excitation and emission wavelengths... we developed a FRET biosensor backbone named "Booster".
Booster is a red-shifted genetically encoded FRET biosensor backbone developed to overcome limitations of CFP/YFP-based FRET biosensors for multiplexing and blue-light optogenetic compatibility.
To overcome these problems, here, we have developed FRET biosensors with red-shifted excitation and emission wavelengths... we developed a FRET biosensor backbone named "Booster".
Booster is a red-shifted genetically encoded FRET biosensor backbone developed to overcome limitations of CFP/YFP-based FRET biosensors for multiplexing and blue-light optogenetic compatibility.
To overcome these problems, here, we have developed FRET biosensors with red-shifted excitation and emission wavelengths... we developed a FRET biosensor backbone named "Booster".
Booster is a red-shifted genetically encoded FRET biosensor backbone developed to overcome limitations of CFP/YFP-based FRET biosensors for multiplexing and blue-light optogenetic compatibility.
To overcome these problems, here, we have developed FRET biosensors with red-shifted excitation and emission wavelengths... we developed a FRET biosensor backbone named "Booster".
Booster is a red-shifted genetically encoded FRET biosensor backbone developed to overcome limitations of CFP/YFP-based FRET biosensors for multiplexing and blue-light optogenetic compatibility.
To overcome these problems, here, we have developed FRET biosensors with red-shifted excitation and emission wavelengths... we developed a FRET biosensor backbone named "Booster".
Booster is a red-shifted genetically encoded FRET biosensor backbone developed to overcome limitations of CFP/YFP-based FRET biosensors for multiplexing and blue-light optogenetic compatibility.
To overcome these problems, here, we have developed FRET biosensors with red-shifted excitation and emission wavelengths... we developed a FRET biosensor backbone named "Booster".
The authors developed red-shifted FRET biosensors and a biosensor backbone named Booster by choosing mKOκ and mKate2 and optimizing fluorescent protein order and modulatory domains.
We chose mKOκ and mKate2 as the favorable donor and acceptor pair by calculating the Förster distance. By optimizing the order of fluorescent proteins and modulatory domains of the FRET biosensors, we developed a FRET biosensor backbone named "Booster".
Booster is a red-shifted genetically encoded FRET biosensor backbone developed by optimizing fluorescent protein order and modulatory domains.
To overcome these problems, here, we have developed FRET biosensors with red-shifted excitation and emission wavelengths. We chose mKOκ and mKate2 as the favorable donor and acceptor pair by calculating the Förster distance. By optimizing the order of fluorescent proteins and modulatory domains of the FRET biosensors, we developed a FRET biosensor backbone named "Booster".
Booster is a red-shifted genetically encoded FRET biosensor backbone developed by optimizing fluorescent protein order and modulatory domains.
To overcome these problems, here, we have developed FRET biosensors with red-shifted excitation and emission wavelengths. We chose mKOκ and mKate2 as the favorable donor and acceptor pair by calculating the Förster distance. By optimizing the order of fluorescent proteins and modulatory domains of the FRET biosensors, we developed a FRET biosensor backbone named "Booster".
Booster is a red-shifted genetically encoded FRET biosensor backbone developed by optimizing fluorescent protein order and modulatory domains.
To overcome these problems, here, we have developed FRET biosensors with red-shifted excitation and emission wavelengths. We chose mKOκ and mKate2 as the favorable donor and acceptor pair by calculating the Förster distance. By optimizing the order of fluorescent proteins and modulatory domains of the FRET biosensors, we developed a FRET biosensor backbone named "Booster".
Booster is a red-shifted genetically encoded FRET biosensor backbone developed by optimizing fluorescent protein order and modulatory domains.
To overcome these problems, here, we have developed FRET biosensors with red-shifted excitation and emission wavelengths. We chose mKOκ and mKate2 as the favorable donor and acceptor pair by calculating the Förster distance. By optimizing the order of fluorescent proteins and modulatory domains of the FRET biosensors, we developed a FRET biosensor backbone named "Booster".
Booster is a red-shifted genetically encoded FRET biosensor backbone developed by optimizing fluorescent protein order and modulatory domains.
To overcome these problems, here, we have developed FRET biosensors with red-shifted excitation and emission wavelengths. We chose mKOκ and mKate2 as the favorable donor and acceptor pair by calculating the Förster distance. By optimizing the order of fluorescent proteins and modulatory domains of the FRET biosensors, we developed a FRET biosensor backbone named "Booster".
Booster is a red-shifted genetically encoded FRET biosensor backbone developed by optimizing fluorescent protein order and modulatory domains.
To overcome these problems, here, we have developed FRET biosensors with red-shifted excitation and emission wavelengths. We chose mKOκ and mKate2 as the favorable donor and acceptor pair by calculating the Förster distance. By optimizing the order of fluorescent proteins and modulatory domains of the FRET biosensors, we developed a FRET biosensor backbone named "Booster".
Booster is a red-shifted genetically encoded FRET biosensor backbone developed by optimizing fluorescent protein order and modulatory domains.
To overcome these problems, here, we have developed FRET biosensors with red-shifted excitation and emission wavelengths. We chose mKOκ and mKate2 as the favorable donor and acceptor pair by calculating the Förster distance. By optimizing the order of fluorescent proteins and modulatory domains of the FRET biosensors, we developed a FRET biosensor backbone named "Booster".
Booster-PKA was used to present PKA activity in living tissues of transgenic mice.
Finally, we presented PKA activity in living tissues of transgenic mice expressing Booster-PKA.
Booster-PKA was used to present PKA activity in living tissues of transgenic mice.
Finally, we presented PKA activity in living tissues of transgenic mice expressing Booster-PKA.
Booster-PKA was used to present PKA activity in living tissues of transgenic mice.
Finally, we presented PKA activity in living tissues of transgenic mice expressing Booster-PKA.
Booster-PKA was used to present PKA activity in living tissues of transgenic mice.
Finally, we presented PKA activity in living tissues of transgenic mice expressing Booster-PKA.
Booster-PKA was used to present PKA activity in living tissues of transgenic mice.
Finally, we presented PKA activity in living tissues of transgenic mice expressing Booster-PKA.
Booster-PKA was used to present PKA activity in living tissues of transgenic mice.
Finally, we presented PKA activity in living tissues of transgenic mice expressing Booster-PKA.
Booster-PKA was used to present PKA activity in living tissues of transgenic mice.
Finally, we presented PKA activity in living tissues of transgenic mice expressing Booster-PKA.
Booster-PKA was used to present PKA activity in living tissues of transgenic mice.
Finally, we presented PKA activity in living tissues of transgenic mice expressing Booster-PKA.
Booster-PKA was used to present PKA activity in living tissues of transgenic mice.
Finally, we presented PKA activity in living tissues of transgenic mice expressing Booster-PKA.
Booster-PKA was used to present PKA activity in living tissues of transgenic mice expressing Booster-PKA.
Finally, we presented PKA activity in living tissues of transgenic mice expressing Booster-PKA.
Booster-PKA was used to present PKA activity in living tissues of transgenic mice expressing Booster-PKA.
Finally, we presented PKA activity in living tissues of transgenic mice expressing Booster-PKA.
Booster-PKA was used to present PKA activity in living tissues of transgenic mice expressing Booster-PKA.
Finally, we presented PKA activity in living tissues of transgenic mice expressing Booster-PKA.
Booster-PKA was used to present PKA activity in living tissues of transgenic mice expressing Booster-PKA.
Finally, we presented PKA activity in living tissues of transgenic mice expressing Booster-PKA.
Booster-PKA was used to present PKA activity in living tissues of transgenic mice expressing Booster-PKA.
Finally, we presented PKA activity in living tissues of transgenic mice expressing Booster-PKA.
Booster-PKA was used to present PKA activity in living tissues of transgenic mice expressing Booster-PKA.
Finally, we presented PKA activity in living tissues of transgenic mice expressing Booster-PKA.
Booster-PKA was used to present PKA activity in living tissues of transgenic mice expressing Booster-PKA.
Finally, we presented PKA activity in living tissues of transgenic mice expressing Booster-PKA.
Booster biosensors are effective and versatile imaging tools in vitro and in vivo.
Collectively, the results demonstrate the effectiveness and versatility of Booster biosensors as an imaging tool in vitro and in vivo.
Booster biosensors are effective and versatile imaging tools in vitro and in vivo.
Collectively, the results demonstrate the effectiveness and versatility of Booster biosensors as an imaging tool in vitro and in vivo.
Booster biosensors are effective and versatile imaging tools in vitro and in vivo.
Collectively, the results demonstrate the effectiveness and versatility of Booster biosensors as an imaging tool in vitro and in vivo.
Booster biosensors are effective and versatile imaging tools in vitro and in vivo.
Collectively, the results demonstrate the effectiveness and versatility of Booster biosensors as an imaging tool in vitro and in vivo.
Booster biosensors are effective and versatile imaging tools in vitro and in vivo.
Collectively, the results demonstrate the effectiveness and versatility of Booster biosensors as an imaging tool in vitro and in vivo.
Booster biosensors are effective and versatile imaging tools in vitro and in vivo.
Collectively, the results demonstrate the effectiveness and versatility of Booster biosensors as an imaging tool in vitro and in vivo.
Booster biosensors are effective and versatile imaging tools in vitro and in vivo.
Collectively, the results demonstrate the effectiveness and versatility of Booster biosensors as an imaging tool in vitro and in vivo.
Booster biosensors are effective and versatile imaging tools in vitro and in vivo.
Collectively, the results demonstrate the effectiveness and versatility of Booster biosensors as an imaging tool in vitro and in vivo.
Booster biosensors are effective and versatile imaging tools in vitro and in vivo.
Collectively, the results demonstrate the effectiveness and versatility of Booster biosensors as an imaging tool in vitro and in vivo.
Booster biosensors are effective and versatile imaging tools in vitro and in vivo.
Collectively, the results demonstrate the effectiveness and versatility of Booster biosensors as an imaging tool in vitro and in vivo.
Booster biosensors are effective and versatile imaging tools in vitro and in vivo.
Collectively, the results demonstrate the effectiveness and versatility of Booster biosensors as an imaging tool in vitro and in vivo.
Booster biosensors are effective and versatile imaging tools in vitro and in vivo.
Collectively, the results demonstrate the effectiveness and versatility of Booster biosensors as an imaging tool in vitro and in vivo.
Booster biosensors are effective and versatile imaging tools in vitro and in vivo.
Collectively, the results demonstrate the effectiveness and versatility of Booster biosensors as an imaging tool in vitro and in vivo.
Booster biosensors are effective and versatile imaging tools in vitro and in vivo.
Collectively, the results demonstrate the effectiveness and versatility of Booster biosensors as an imaging tool in vitro and in vivo.
Booster biosensors are effective and versatile imaging tools in vitro and in vivo.
Collectively, the results demonstrate the effectiveness and versatility of Booster biosensors as an imaging tool in vitro and in vivo.
Booster biosensors are effective and versatile imaging tools in vitro and in vivo.
Collectively, the results demonstrate the effectiveness and versatility of Booster biosensors as an imaging tool in vitro and in vivo.
Approval Evidence
The performance of the protein kinase A (PKA) biosensor based on the Booster backbone (Booster-PKA) was comparable to that of AKAR3EV
Source:
The performance of the protein kinase A (PKA) biosensor based on the Booster backbone (Booster-PKA) was comparable to that of AKAR3EV.
Source:
The performance of the protein kinase A (PKA) biosensor based on the Booster backbone (Booster-PKA) was comparable to that of AKAR3EV, a previously developed FRET biosensor comprising CFP and YFP.
Source:
Booster-PKA can be used simultaneously with a CFP/YFP-based ERK FRET biosensor to monitor activities of two protein kinases.
we first showed simultaneous monitoring of activities of two protein kinases with Booster-PKA and ERK FRET biosensors based on CFP and YFP
Source:
Booster-PKA enabled simultaneous monitoring of two protein kinase activities together with a CFP/YFP-based ERK FRET biosensor.
For the proof of concept, we first showed simultaneous monitoring of activities of two protein kinases with Booster-PKA and ERK FRET biosensors based on CFP and YFP.
Source:
Booster-PKA performance was comparable to AKAR3EV.
The performance of the protein kinase A (PKA) biosensor based on the Booster backbone (Booster-PKA) was comparable to that of AKAR3EV
Source:
Booster-PKA performance was comparable to AKAR3EV.
The performance of the protein kinase A (PKA) biosensor based on the Booster backbone (Booster-PKA) was comparable to that of AKAR3EV
Source:
Booster-PKA performance was comparable to that of AKAR3EV.
The performance of the protein kinase A (PKA) biosensor based on the Booster backbone (Booster-PKA) was comparable to that of AKAR3EV, a previously developed FRET biosensor comprising CFP and YFP.
Source:
Booster-PKA can be used simultaneously with a CFP/YFP-based ERK FRET biosensor to monitor two protein kinase activities.
we first showed simultaneous monitoring of activities of two protein kinases with Booster-PKA and ERK FRET biosensors based on CFP and YFP
Source:
Booster-PKA enabled monitoring of PKA activation driven by Beggiatoa photoactivated adenylyl cyclase.
we showed monitoring of PKA activation by Beggiatoa photoactivated adenylyl cyclase, an optogenetic generator of cyclic AMP
Source:
Booster-PKA is compatible with blue-light optogenetic activation of cAMP signaling using Beggiatoa photoactivated adenylyl cyclase.
Second, we showed monitoring of PKA activation by Beggiatoa photoactivated adenylyl cyclase, an optogenetic generator of cyclic AMP.
Source:
Booster-PKA was used to monitor PKA activation driven by Beggiatoa photoactivated adenylyl cyclase.
Second, we showed monitoring of PKA activation by Beggiatoa photoactivated adenylyl cyclase, an optogenetic generator of cyclic AMP.
Source:
Booster-PKA was used to present PKA activity in living tissues of transgenic mice.
Finally, we presented PKA activity in living tissues of transgenic mice expressing Booster-PKA.
Source:
Booster-PKA was used to present PKA activity in living tissues of transgenic mice.
Finally, we presented PKA activity in living tissues of transgenic mice expressing Booster-PKA.
Source:
Booster-PKA was used to present PKA activity in living tissues of transgenic mice expressing Booster-PKA.
Finally, we presented PKA activity in living tissues of transgenic mice expressing Booster-PKA.
Source:
Comparisons
Source-stated alternatives
The abstract directly compares Booster-PKA to AKAR3EV and also pairs it experimentally with an ERK CFP/YFP FRET biosensor for multiplexed monitoring.; AKAR3EV is the explicit comparator mentioned in the abstract. Standard CFP/YFP-based FRET biosensors are the broader alternative class contrasted with Booster-PKA.
Source:
The abstract directly compares Booster-PKA to AKAR3EV and also pairs it experimentally with an ERK CFP/YFP FRET biosensor for multiplexed monitoring.
Source:
AKAR3EV is the explicit comparator mentioned in the abstract. Standard CFP/YFP-based FRET biosensors are the broader alternative class contrasted with Booster-PKA.
Source-backed strengths
The reported performance of Booster-PKA was comparable to that of AKAR3EV, providing a benchmark against an established PKA biosensor. It was also demonstrated to enable simultaneous monitoring of two protein kinase activities together with a CFP/YFP-based ERK FRET biosensor.
Source:
performance comparable to AKAR3EV
Source:
used for simultaneous monitoring with another kinase biosensor
Source:
used with Beggiatoa photoactivated adenylyl cyclase
Source:
demonstrated in living tissues of transgenic mice
Compared with AKAR3EV
The abstract directly compares Booster-PKA to AKAR3EV and also pairs it experimentally with an ERK CFP/YFP FRET biosensor for multiplexed monitoring.; AKAR3EV is the explicit comparator mentioned in the abstract. Standard CFP/YFP-based FRET biosensors are the broader alternative class contrasted with Booster-PKA.
Shared frame: source-stated alternative in extracted literature
Strengths here: performance comparable to AKAR3EV; used in vitro and in vivo; used for simultaneous monitoring with another kinase biosensor.
Relative tradeoffs: abstract does not report quantitative performance metrics.
Source:
The abstract directly compares Booster-PKA to AKAR3EV and also pairs it experimentally with an ERK CFP/YFP FRET biosensor for multiplexed monitoring.
Source:
AKAR3EV is the explicit comparator mentioned in the abstract. Standard CFP/YFP-based FRET biosensors are the broader alternative class contrasted with Booster-PKA.
Compared with biosensors
AKAR3EV is the explicit comparator mentioned in the abstract. Standard CFP/YFP-based FRET biosensors are the broader alternative class contrasted with Booster-PKA.
Shared frame: source-stated alternative in extracted literature
Strengths here: performance comparable to AKAR3EV; used in vitro and in vivo; used for simultaneous monitoring with another kinase biosensor.
Relative tradeoffs: abstract does not report quantitative performance metrics.
Source:
AKAR3EV is the explicit comparator mentioned in the abstract. Standard CFP/YFP-based FRET biosensors are the broader alternative class contrasted with Booster-PKA.
Compared with biosensors for active Rho detection
AKAR3EV is the explicit comparator mentioned in the abstract. Standard CFP/YFP-based FRET biosensors are the broader alternative class contrasted with Booster-PKA.
Shared frame: source-stated alternative in extracted literature
Strengths here: performance comparable to AKAR3EV; used in vitro and in vivo; used for simultaneous monitoring with another kinase biosensor.
Relative tradeoffs: abstract does not report quantitative performance metrics.
Source:
AKAR3EV is the explicit comparator mentioned in the abstract. Standard CFP/YFP-based FRET biosensors are the broader alternative class contrasted with Booster-PKA.
Compared with Booster
The abstract directly compares Booster-PKA to AKAR3EV and also pairs it experimentally with an ERK CFP/YFP FRET biosensor for multiplexed monitoring.; AKAR3EV is the explicit comparator mentioned in the abstract. Standard CFP/YFP-based FRET biosensors are the broader alternative class contrasted with Booster-PKA.
Shared frame: source-stated alternative in extracted literature
Strengths here: performance comparable to AKAR3EV; used in vitro and in vivo; used for simultaneous monitoring with another kinase biosensor.
Relative tradeoffs: abstract does not report quantitative performance metrics.
Source:
The abstract directly compares Booster-PKA to AKAR3EV and also pairs it experimentally with an ERK CFP/YFP FRET biosensor for multiplexed monitoring.
Source:
AKAR3EV is the explicit comparator mentioned in the abstract. Standard CFP/YFP-based FRET biosensors are the broader alternative class contrasted with Booster-PKA.
Compared with fluorescent protein based reporters and biosensors
AKAR3EV is the explicit comparator mentioned in the abstract. Standard CFP/YFP-based FRET biosensors are the broader alternative class contrasted with Booster-PKA.
Shared frame: source-stated alternative in extracted literature
Strengths here: performance comparable to AKAR3EV; used in vitro and in vivo; used for simultaneous monitoring with another kinase biosensor.
Relative tradeoffs: abstract does not report quantitative performance metrics.
Source:
AKAR3EV is the explicit comparator mentioned in the abstract. Standard CFP/YFP-based FRET biosensors are the broader alternative class contrasted with Booster-PKA.
Compared with FRET
The abstract directly compares Booster-PKA to AKAR3EV and also pairs it experimentally with an ERK CFP/YFP FRET biosensor for multiplexed monitoring.; AKAR3EV is the explicit comparator mentioned in the abstract. Standard CFP/YFP-based FRET biosensors are the broader alternative class contrasted with Booster-PKA.
Shared frame: source-stated alternative in extracted literature
Strengths here: performance comparable to AKAR3EV; used in vitro and in vivo; used for simultaneous monitoring with another kinase biosensor.
Relative tradeoffs: abstract does not report quantitative performance metrics.
Source:
The abstract directly compares Booster-PKA to AKAR3EV and also pairs it experimentally with an ERK CFP/YFP FRET biosensor for multiplexed monitoring.
Source:
AKAR3EV is the explicit comparator mentioned in the abstract. Standard CFP/YFP-based FRET biosensors are the broader alternative class contrasted with Booster-PKA.
Compared with genetically engineered biosensors
AKAR3EV is the explicit comparator mentioned in the abstract. Standard CFP/YFP-based FRET biosensors are the broader alternative class contrasted with Booster-PKA.
Shared frame: source-stated alternative in extracted literature
Strengths here: performance comparable to AKAR3EV; used in vitro and in vivo; used for simultaneous monitoring with another kinase biosensor.
Relative tradeoffs: abstract does not report quantitative performance metrics.
Source:
AKAR3EV is the explicit comparator mentioned in the abstract. Standard CFP/YFP-based FRET biosensors are the broader alternative class contrasted with Booster-PKA.
Ranked Citations
- 1.